EurekAlert! -
11 Feb 2014 07:00
(University of Kentucky) A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Share this Article